Literature DB >> 18797821

Changes in foveal thickness after vitrectomy for macular edema with branch retinal vein occlusion and intravitreal vascular endothelial growth factor.

Makiko Yamasaki1, Hidetaka Noma, Hideharu Funatsu, Atsushi Minamoto, Tatsuya Mimura, Katsunori Shimada, Hidetoshi Yamashita, Yoshiaki Kiuchi.   

Abstract

Purpose To examine the outcome of vitrectomy for macular edema associated with branch retinal vein occlusion (BRVO) and determine the relationship between the severity of macular edema and the concentration of vascular endothelial growth factor (VEGF) and interleukin-6 (IL-6) in the vitreous fluid. Design Prospective observational case series. Patients and Methods Thirty-four consecutive patients (34 eyes) with macular edema associated with BRVO underwent vitrectomy. Retinal thickness was examined using optical coherence tomography. VEGF and IL-6 levels in the vitreous fluid were determined by enzyme-linked immunosorbent assay. The patients were followed for 6 months and longer after surgery. Results Visual acuity and the retinal thickness at 6 months after operation were significantly improved (P = 0.0042 and P < 0.0001, respectively). There was a significant positive correlation between the vitreous levels of VEGF and improved level of the severity of macular edema. The vitreous levels of VEGF were significantly higher in patients who showed greater improvement in the severity of macular edema (r = 0.4277, P = 0.0116). The vitreous levels of IL-6 were not significantly correlated with improvement in the severity of macular edema (r = 0.1996, P = 0.2578). Conclusion Vitrectomy appears effective for treatment of macular edema with BRVO. A higher VEGF level in the vitreous fluid may be associated with greater improvement of macular edema with BRVO.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18797821     DOI: 10.1007/s10792-008-9216-4

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  21 in total

1.  Outcomes of vitreoretinal surgery for complications of branch retinal vein occlusion.

Authors:  A Amirikia; I U Scott; T G Murray; H W Flynn; W E Smiddy; W J Feuer
Journal:  Ophthalmology       Date:  2001-02       Impact factor: 12.079

2.  The natural course of temporal retinal branch vein occlusion.

Authors:  F A Gutman; H Zegarra
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1974 Mar-Apr

3.  IL-6 increases endothelial permeability in vitro.

Authors:  N Maruo; I Morita; M Shirao; S Murota
Journal:  Endocrinology       Date:  1992-08       Impact factor: 4.736

4.  Laser treatment and the mechanism of edema reduction in branch retinal vein occlusion.

Authors:  A Arnarsson; E Stefánsson
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-03       Impact factor: 4.799

5.  Vitrectomy for macular edema combined with retinal vein occlusion.

Authors:  N Tachi; Y Hashimoto; N Ogino
Journal:  Doc Ophthalmol       Date:  1999       Impact factor: 2.379

6.  Surgical posterior vitreous detachment combined with gas/air tamponade for treating macular edema associated with branch retinal vein occlusion: retinal tomography and visual outcome.

Authors:  S Saika; T Tanaka; T Miyamoto; Y Ohnishi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2001-10       Impact factor: 3.117

7.  Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema.

Authors:  Hideharu Funatsu; Hidetoshi Yamashita; Tomohiro Ikeda; Tatsuya Mimura; Shuichiro Eguchi; Sadao Hori
Journal:  Ophthalmology       Date:  2003-09       Impact factor: 12.079

8.  Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid.

Authors:  D R Senger; S J Galli; A M Dvorak; C A Perruzzi; V S Harvey; H F Dvorak
Journal:  Science       Date:  1983-02-25       Impact factor: 47.728

9.  Interleukin 6 induces the expression of vascular endothelial growth factor.

Authors:  T Cohen; D Nahari; L W Cerem; G Neufeld; B Z Levi
Journal:  J Biol Chem       Date:  1996-01-12       Impact factor: 5.157

10.  Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. A randomized clinical trial. Branch Vein Occlusion Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1986-01
View more
  2 in total

1.  Visual acuity and foveal thickness after vitrectomy for macular edema associated with branch retinal vein occlusion: a case series.

Authors:  Hidetaka Noma; Hideharu Funatsu; Tatsuya Mimura; Shuichiro Eguchi; Katsunori Shimada
Journal:  BMC Ophthalmol       Date:  2010-04-29       Impact factor: 2.209

2.  Effects of Vitrectomy on Recurrent Macular Edema due to Branch Retinal Vein Occlusion after Intravitreal Injection of Bevacizumab.

Authors:  Tatsuya Yunoki; Keiichi Mitarai; Shuichiro Yanagisawa; Tsuyoshi Kato; Nobuo Ishida; Atsushi Hayashi
Journal:  J Ophthalmol       Date:  2013-02-20       Impact factor: 1.909

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.